JAZZ — JAZZ PHARMACEUTICALS PLC

Ownership history in Caption Management, LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in JAZZ PHARMACEUTICALS PLC (JAZZ). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.35% (2020 Q2)
Avg. % of fund
0.15%
First filed
2020 Q2
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 10,747 -245,453 -95.8% 0.01% $1.8M $170.00
2025 Q3 UNCHANGED 256,200 — 0% 0.26% $33.8M $131.80
2025 Q2 ADDED 256,200 +95,800 +59.7% 0.30% $27.2M $106.12
2025 Q1 ADDED 160,400 +130,400 +434.7% 0.19% $19.9M $124.15
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    JAZZ price (monthly, adj. close)

Other funds also holding JAZZ

As of 2025 Q4 — sorted by position size

EcoR1 Capital, LLC 3Y 7Y 13.16% Krensavage Asset Management, LLC 3Y 7Y 10.08% Saturn V Capital Management LP 3Y 7.74% Sofinnova Investments, Inc. 3Y 7Y 7.04% Polaris Capital Management, LLC 3Y 7Y 6.1% Iron Triangle Partners LP 3Y 5.68% GMT CAPITAL CORP 3Y 7Y 5.66% GOLDENTREE ASSET MANAGEMENT LP 3Y 7Y 3.87% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 3.35% Resolute Capital Asset Partners LLC 3Y 3.29%
← Back to Caption Management, LLC Holdings